These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6342786)

  • 1. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
    Asmar R; Guez D; Malbezin M; Brault Y; de Cordoue A; Barrandon S; Bruxelles MC; Chastang C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1083-7. PubMed ID: 8572850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension.
    Hall WD; Weber MA; Ferdinand K; Flamenbaum W; Marbury T; Jain AK; Weidler D; Weiss R; Herron J; Codispoti J
    J Hum Hypertens; 1994 Aug; 8(8):571-5. PubMed ID: 7990083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension.
    Levine B; Lee W; Boyd G; Chrysant S; Dawson J; Gardner T; Hill G; Vergis J; Codispoti J; Stokes A
    J Fam Pract; 1995 Jul; 41(1):75-80. PubMed ID: 7798068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension and well-being: a study with indapamide].
    Rodrigues T; Macieira L; Alfaiate A; Gouveia-Oliveira A; Matias F; Corrêa-Nunes A; Carrageta MO
    Rev Port Cardiol; 1994 Jan; 13(1):21-8, 7. PubMed ID: 8155346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indapamide in hypertension: a study in general practice of new or previously poorly controlled patients.
    Wheeley MS; Bolton JC; Campbell DB
    Pharmatherapeutica; 1982; 3(2):143-52. PubMed ID: 7100225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative effects of nifedipine and indapamide in the treatment of arterial hypertension].
    Chaignon M; Lucsko M; Rapoud JP; Aubert P; Guédon J
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():67-72. PubMed ID: 3937509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
    Nikas S; Rizos E; Milionis H; Bairaktari E; Kalaitzidis R; Siamopoulos K; Elisaf M
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
    Verho M; Rangoonwala B; Beloso M; Maass L; Bender R; Garduno D
    Drugs Exp Clin Res; 1986; 12(5):385-91. PubMed ID: 3522159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA; Punzi CF
    J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
    Meywald W; Maass L; Verho M; Rangoonwala B
    Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indapamide in the treatment of essential arterial hypertension in the elderly.
    Van Hee W; Thomas J; Brems H
    Postgrad Med J; 1981; 57 Suppl 2():29-33. PubMed ID: 7033944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.